NJF-14145-86051
2 vaccinations
1 coded response
6 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 405 / KY
- Registered
- 2021-04-14
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-12
Dose 1 — Moderna
-
2021-04-12
Dose 2 — Moderna
-
2021-04-14
Registered in v-safe
-
2021-04-14
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-04-14
Report sent to call center — days 1–6 daily, dose 2Be unable to work · Be unable to do your normal daily activities1 call case(s)
- 2021-04-15
- 2021-05-03
-
2021-05-10
Survey response — day 28, dose 2MedDRA: Nasopharyngitis, Oropharyngeal pain — Feeling: FairFree text: Sore throat, cold symptomsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-17
- 2021-07-12
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-12 | Moderna | |
| 2 | 2021-04-12 | Moderna |
Call center
1 call center case
1 priority 2/3 (triaged and no follow up)
Free text
Release 8 — day 28, dose 2
Symptoms: Sore throat, cold symptoms
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Nasopharyngitis | ✓ | ✓ | ✓ |
| SD | Oropharyngeal pain | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release